PLEASANTON, Calif., Jan. 28 /PRNewswire/ -- Aesthera's Isolaz platform was hailed by New York Dermatologist, Dr. Doris Day, as a unique in-office treatment for Rosacea on the January 21st show of ABC News' Good Morning America.
The Isolaz developed by Aesthera Corporation is a proprietary combination of pneumatic energy and broad band light. Best recognized as the gold standard for acne treatment, the Isolaz is the only laser or light based device cleared for the treatment of inflammatory acne, comedonal acne and pustular acne. Doris Day, MD, FAAD, a board certified dermatologist who practices in New York City has treated several hundred patients for Acne now uses a different treatment tip on the Isolaz for the in-office treatment for Rosacea. "The Isolaz is an extremely effective treatment offering for my Rosacea patients. The procedure takes under 10 minutes, and is associated with no pain or downtime," she says. "The Isolaz is invaluable, especially for patients who are resistant to antibiotics or choose not to take them," she adds.
According to the National Rosacea Society, 14 million Americans suffer from Rosacea. Rosacea manifests itself as acute redness on the face, cheeks and forehead. Its acne like effects often cause significant psychological harm, impacting patients' self esteem and self confidence. "While there are no cures for Rosacea, Isolaz provides a safe and effective treatment option to control this life disruptive skin disorder," Dr. Day concludes.
About Doris Day, MD
Dr. Doris Day is a board certified dermatologist specializing in laser, cosmetic and surgical dermatology Her private practice, Day Dermatology and Aesthetics is located in New York City. To contact Dr. Day or schedule an appointment, please call 212.772.0740. To learn more about her practice, please visit www.myclearskin.com
About Photopneumatic™ Technology
Photopneumatic Therapy, that powers the Isolaz™ and Isolaz Pro™ system, is a proprietary combination of pneumatic energy and broad band light. Photopneumatic devices are the only laser or light based devices cleared for the treatment of inflammatory acne, comedonal acne and pustular acne. They are also cleared for the treatment of mild to moderate inflammatory acne. Photopneumatic treatments have an immediate visible impact on acne 24 – 48 hour post first treatment and are painless. Facial treatments take approximately 10 minutes, require no anesthetics or numbing creams and provide additional cosmetic benefits such as smoother appearing skin. Additionally, Photopneumatic devices are also FDA cleared for the treatment of vascular and pigmented lesions and hair removal.
About Aesthera Corporation
Aesthera (www.AESTHERA.com) develops, manufactures and markets light-based aesthetic treatment systems - the Isolaz™ and Isolaz Pro ™ platforms - based on proprietary Photopneumatic™ technology. Clinically proven to be pain-free and up to seven times faster than currently available light-based aesthetic systems, Aesthera's revolutionary systems combine the proven properties of therapeutic light with gentle pneumatic energy to more effectively work on dermal and epidermal skin targets.
SOURCE Aesthera Corporation